Clinitech Laboratory IPO Details, Date, Allotment

Clinitech Laboratory IPO is a fixed-price issue aiming to raise ₹5.78 crores. The entire issue consists of 6.02 lakh new equity shares.

Clinitech Laboratory IPO is open for subscription on July 25, 2024, and closes on July 29, 2024. The allotment for the IPO is expected on July 30, 2024. V.L.Infraprojects IPO will be listed on BSE SME with a listing date fixed as August 1, 2024.

Source from Clinitech Laboratory IPO RHP

Clinitech Laboratory IPO Details, Date, Allotment

Clinitech Laboratory IPO Details

Clinitech Laboratory IPO
Open DateJuly 25, 2024
Close DateJuly 29, 2024
Listing DateAugust 1, 2024
IPO SizeA total of Rs ₹5.78 crores and 6.02 lakh shares
Fresh Issue6,02,400 Equity Shares
Face Value₹10 per share
IPO Price Band₹96 per share
IPO Listing onBSE SME
Lot Size1200 Shares
OFSN.A
Share Offered to Retail50%
Share Offered to HNI15%

Clinitech Laboratory IPO Date

  • IPO Open Date: July 25, 2024
  • IPO Close Date: July 29, 2024
  • Allotment: July 30, 2024
  • Refunds: July 31, 2024
  • Shares Credit to Demat: July 31, 2024
  • Listing Date: August 1, 2024

Lot Size

ApplicationLotsSharesAmount
Retail (Min)11200₹115,200
Retail (Max)11200₹115,200
HNI (Min)22,400₹230,400

Clinitech Laboratory IPO GMP (Grey Market Premium)

If you want to know Clinitech Laboratory IPO GMP (Grey Market Premium) then please visit our IPO GMP section and get daily updates on grey market premium. We update here all IPOs GMP.

Clinitech Laboratory IPO Subscription Status

Clinitech Laboratory IPO subscription starts on July 25, 2024, To get live IPO subscription status data go to our IPO Subscription section and see any ongoing IPO Subscription Status.

Clinitech Laboratory IPO Allotment Status

To check the Clinitech Laboratory IPO allotment status go to the IPO registrar website ”Bigshare Services Private Limited” or go to IPO Allotment>>.
You can find here any IPO allotment status. Following some stapes.

  1. Go to the Link given above.
  2. Select the IPO Name
  3. Enter your PAN/ DP ID/ Application No
  4. Submit details and get the allotment status.

Know About Company

1. Foundation and Services

  • Established: 1990
  • Industry: Diagnostic and Health Testing Services
  • Primary Services: Provides a wide range of diagnostic tests and health services.

2. Types of Tests Offered

Clinitech Laboratory performs over 150 different types of tests. These tests are categorized into:

  • Biochemical Tests: Analyzing chemicals in the body’s fluids.
  • Immunology Tests: Checking immune system functions and disorders.
  • Hematology Tests: Examining blood for diseases and conditions.
  • Molecular Biology Tests: Studying DNA, RNA, and proteins for genetic conditions.
  • Serology Tests: Detecting antibodies and antigens in the blood.
  • Microbiology Tests: Identifying bacteria, viruses, and fungi.
  • Histopathology Tests: Analyzing tissue samples for diseases.

3. Diagnostic Centers

  • Locations: 8 centres in and around Thane and Navi Mumbai.
  • Test Volume: Conducts over 3 lakh tests annually.

4. Accreditation and Technology

  • Accreditation: NABL (National Accreditation Board for Testing and Calibration Laboratories).
  • Standards: Accredited under ISO 15189:2012 for medical testing.
  • Facilities: Equipped with modern technology and high-quality equipment.

Clinitech Laboratory Limited Financial Information (Restated)

Period Ended31 Mar 202431 Mar 202331 Mar 202231 Mar 2021
Assets (₹ Lakhs)560.79603.33368.74273.32
Revenue (₹ Lakhs)643.92636.34645.70459.63
Profit After Tax (PAT) (₹ Lakhs)37.1261.3151.2640.24
Net Worth (₹ Lakhs)354.80238.08184.81139.03
Reserves and Surplus (₹ Lakhs)186.8088.0834.8172.37
Total Borrowing (₹ Lakhs)86.31102.9188.6153.67

Financial KPIs of Clinitech Laboratory Limited

ParticularsFiscal 2024Fiscal 2023Fiscal 2022
Total Revenue (₹ Lakhs)643.92636.34645.70
EBITDA (₹ Lakhs)101.66136.69113.92
EBITDA Margin (%)15.87%21.53%17.64%
PAT (₹ Lakhs)37.1261.3151.26
PAT Margin (%)5.76%9.63%7.94%
Net Debt (₹ Lakhs)16.1824.5678.25
Equity Share Capital (₹ Lakhs)168.00150.00150.00
Net Worth (₹ Lakhs)354.80238.08184.81
RONW (%)10.46%25.75%27.74%
EPS (Basic & Diluted) (₹)2.374.093.42

Clinitech Laboratory IPO Valuation – FY2024

Peer Group

  • Dr. Lal Pathlabs
  • Thyrocare
  • Krsnaa Diagnostics

Clinitech Laboratory Limited IPO Registrar

BIGSHARE SERVICES PRIVATE LIMITED
S6-2, 6th Floor, Pinnacle Business Park, Mahakali Caves Road, Next to Ahura
Centre, Andheri East, Mumbai – 400 093, Maharashtra, India
Tel. No.: +91 22 6263 8200
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com
Investor Grievance Email: investor@bigshareonline.com

Clinitech Laboratory Limited IPO Lead Manager

INVENTURE MERCHANT BANKER SERVICES PRIVATE LIMITED
2ndFloor, Viraj Towers, Near Andheri Flyover (North End),
Western Express Highway, Andheri (East),
Mumbai – 400069, Maharashtra
Tel No: +91 22 4075 1500
Email: compliance@inventuremerchantbanker.com
Investor Grievance Email: redressal@inventuremerchantbanker.com
Website:www.inventuremerchantbanker.com

Clinitech Laboratory Limited Contact

Clinitech Laboratory Limited
AL-1/545, Sector 16, Airoli
Opposite Radhikabai Meghe Vidyalaya
Navi Mumbai, Thane – 400708,
Phone: +91 22 27792281
Email: ipo@clinitechlab.com
Website: https://clinitechlab.com/

Clinitech Laboratory IPO Application Form PDF

To download the Clinitech Laboratory Limited IPO application form Check out the Application Form Download ASBA IPO Forms PDF.

Clinitech Laboratory Limited IPO FAQs

What is the Clinitech Laboratory Limited IPO?

The Clinitech Laboratory IPO is a fixed-price issue where the company is offering 6.02 lakh new equity shares to raise ₹5.78 crores. This is an opportunity for investors to buy shares of Clinitech Laboratory Limited.

When will the Clinitech Laboratory Limited IPO shares be listed?

The shares are expected to be listed on BSE SME on August 1, 2024.

How can I apply for the Clinitech Laboratory IPO?

You can apply for the IPO through the ASBA (Application Supported by Blocked Amount) process via your bank’s net banking platform or through a broker.

Rate this post

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top